Skip to main content
Fig. 2 | Journal for ImmunoTherapy of Cancer

Fig. 2

From: Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment

Fig. 2

Melanoma brain metastasis response to concurrent SRS and pembrolizumab. Shown are representative responses in a single patient who received SRS with concurrent pembro to multiple brain metastases. T1, gadolinium-enhanced axial images of three treated lesions on pre-SRS planning MRI and first follow-up MRI illustrate PR in left panels and CR in middle and right panels with no contrast-enhancing focus visible on follow-up MRI

Back to article page